Literature DB >> 14360511

[Morphology of Pneumocystis carinii and pathogenesis of Pneumocystis carinii pneumonia].

O JIROVEC, J VANEK.   

Abstract

Entities:  

Keywords:  PNEUMONIA/in infant and child; PROTOZOA; PROTOZOAN INFECTIONS/in infant and child

Mesh:

Year:  1954        PMID: 14360511

Source DB:  PubMed          Journal:  Zentralbl Allg Pathol        ISSN: 0044-4030


× No keyword cloud information.
  14 in total

1.  A case of osteopetrosis (Albers-Schonberg) with intercurrent Pneumocystis pneumonitis.

Authors:  W AHERNE
Journal:  Arch Dis Child       Date:  1960-10       Impact factor: 3.791

2.  Pneumocystis pneumonia. Report of three cases in adults and one in a child with a discussion of the radiological appearances and predisposing factors.

Authors:  W F WHITE; H M SAXTON; I M DAWSON
Journal:  Br Med J       Date:  1961-11-18

3.  The etiology of interstitial pneumonia identification as Hansenula anomala of a yeast isolated from lungs of infants.

Authors:  C J WANG; J SCHWARZ
Journal:  Mycopathol Mycol Appl       Date:  1958-09-29

4.  [Electron microscopy of Pneumocystis carinii].

Authors:  W WESSEL; D RICKEN
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1958

5.  Fourteen personal cases of pneumocystis carinii pneumonia.

Authors:  G BERDNIKOFF
Journal:  Can Med Assoc J       Date:  1959-01-01       Impact factor: 8.262

6.  [Histological studies in experimental pneumocystis pneumonia].

Authors:  D RICKEN
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1958

7.  [On the histochemistry of Pneumocystis carinii].

Authors:  W OPFERKUCH
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1959

8.  Pneumocystis infection and cytomegaly of the lungs in the newborn and adult.

Authors:  H HAMPERL
Journal:  Am J Pathol       Date:  1956 Jan-Feb       Impact factor: 4.307

9.  [Healing and abortive Pneumocystis pneumonia].

Authors:  H HAMPERL
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1957

Review 10.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.